12 Health Care Stocks Moving In Monday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Monday's pre-market session, several healthcare stocks experienced significant movements. Prime Medicine, Traws Pharma, and Tharimmune saw notable gains, while Ensysce Biosciences and Corvus Pharma faced declines. Earnings reports influenced some stock movements.
September 30, 2024 | 12:06 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Bionomics stock declined by 10.13% to $0.57, indicating negative investor sentiment.
The decline suggests negative sentiment or adverse news impacting investor confidence.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Corvus Pharma shares declined by 11.66% to $4.55, reflecting negative market sentiment.
The decline in share price indicates negative sentiment, possibly due to unfavorable news.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Ensysce Biosciences shares fell 20.8% to $0.23, indicating negative investor sentiment.
The significant drop suggests negative sentiment or adverse news affecting investor confidence.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Estrella Immunopharma shares decreased by 10.93% to $1.06, likely influenced by the Q4 earnings report.
The stock's decline is likely due to negative earnings results, affecting investor confidence.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 85
NEGATIVE IMPACT
Protagenic Therapeutics shares decreased by 11.28% to $0.55, suggesting negative investor sentiment.
The decrease in share price suggests a negative outlook from investors.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 75
NEGATIVE IMPACT
Venus Concept shares decreased by 7.5% to $0.66, reflecting negative market sentiment.
The decrease in share price indicates a negative outlook from investors.
CONFIDENCE 75
IMPORTANCE 55
RELEVANCE 65
POSITIVE IMPACT
Addex Therapeutics shares increased by 13.81% to $10.3, likely influenced by the Q2 earnings report.
The stock's rise is likely due to positive earnings results, boosting investor confidence.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 85
POSITIVE IMPACT
AnaptysBio shares rose 9.82% to $35.0, reflecting positive market sentiment.
The increase in share price indicates a positive outlook from investors.
CONFIDENCE 75
IMPORTANCE 55
RELEVANCE 65
POSITIVE IMPACT
BrainsWay's stock increased by 13.01% to $9.12, indicating positive investor sentiment.
The stock's rise suggests favorable market sentiment, possibly due to positive developments.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Prime Medicine's stock surged by 24.3% to $4.3, indicating strong investor interest and a positive market reaction.
The significant price increase suggests positive sentiment or news, likely attracting more investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Tharimmune shares rose by 14.28% to $2.8, suggesting a positive outlook from investors.
The increase in share price indicates a positive market reaction, possibly due to favorable news.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 75
POSITIVE IMPACT
Traws Pharma's stock increased by 16.2% to $6.67, reflecting positive market sentiment.
The stock's rise indicates favorable investor sentiment, possibly due to positive news or developments.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80